ARTICLE | Company News
Adagio Pharmaceuticals, Cannasat deal
February 15, 2010 8:00 AM UTC
The companies signed a letter of intent granting Cannasat an exclusive option to obtain exclusive, worldwide rights to develop and commercialize Adagio's APL-130277 to treat Parkinson's disease. Cann...